Phase I trial of the mTOR inhibitor everolimus in combination with multi‐agent chemotherapy in relapsed childhood acute lymphoblastic leukemia

Pediatric Blood &Cancer, EarlyView.


from Cancer via ola Kala on Inoreader https://ift.tt/2pS0xaZ
via IFTTT